The heterogenity of AMH depletion models across assays in 12917 women

      A regular Anti-Müllerian hormone diagnosis obtained with different kits is still an open problem to opinion makers in the field of reproductive medicine. As far now the literature points out that the profile of the rate of AMH change varies for available assays. Thus, predominately important is to measure the heterogeneity among kits.
      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect